QUOTIENT SCIENCES COMPLETES INTEGRATION OF DRUG SUBSTANCE INTO TRANSLATIONAL PHARMACEUTICS® PLATFORM
NOTTINGHAM, England, Feb. 17, 2022 /PRNewswire/ -- Quotient Sciences – a global drug development and manufacturing accelerator offering a suite of services to clients in the pharmaceutical and biotech ...
SALT LAKE CITY--(BUSINESS WIRE)--Quotient (NYSE: QUOT), a leading digital promotions and media technology company, today announced the expiration of the waiting period under the Hart-Scott-Rodino ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results